There are 2867 resources available
1635P - Impact of treatment sequence on clinical outcomes in patients with thymic carcinoma
Presenter: Akiko Tateishi
Session: Poster session 05
1636P - Prognostic indication for malignant peritoneal mesothelioma with tumor-specific and inflammatory biomarkers
Presenter: Keval Yerigeri
Session: Poster session 05
1637P - Impact of immune-related adverse events (irAEs) and survival (OS) in a cohort of MPM patients (p) treated with immunotherapy (IT)
Presenter: Susana Cedres Perez
Session: Poster session 05
1638P - Risk and prognosis of secondary lung cancer after radiation therapy for thoracic malignancies
Presenter: yujia zheng
Session: Poster session 05
1639P - MACADAM (MesotheliomA ClinicAl DatA platforM): A reference database as a tool for large-scale collaborative research
Presenter: Luigi Cerbone
Session: Poster session 05
1640TiP - PECATI: A phase II trial to evaluate the efficacy and safety of lenvatinib in combination with pembrolizumab in pretreated advanced b3-thymoma (B3-T) and thymic carcinoma (TC)
Presenter: Jordi Remon Masip
Session: Poster session 05
1641TiP - Adjuvant nivolumab with chemotherapy in pleural mesothelioma: The NICITA trial
Presenter: Rajiv Shah
Session: Poster session 06
1642TiP - ENSURE: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study
Presenter: Luca Cantini
Session: Poster session 06
1643TiP - First-in-human dose-escalation and expansion study (MITOPE) to evaluate mitochondrial PRX3 inhibition by RSO-021 in patients with mesothelioma and other advanced solid tumors
Presenter: Sean Dulloo
Session: Poster session 06
1665P - Genomic mutational landscape of solid tumors: Preliminary results from ROME trial
Presenter: Andrea Botticelli
Session: Poster session 06